- CEO, Nonpareil Biotechnologies
- Joseph is an biotechnology investor and entrepreneur with 24 years of experience in the biotechnology, pharmaceuticals and medical technology industries. Beginning his investment career as a biotechnology analyst at JP Morgan Securities, Joseph was later a bio-pharmaceutical analyst at The Dreyfus Corporation, Scudder Investments and Feirstein Capital Management.
- Most recently in late 2015, Joseph founded Nonpareil Biotechnologies, a biotechnology accelerator that translates early research into new innovative drug therapies and develops biosignature analytic technologies.
- During his career, Joseph has invested over $30 billion of institutional capital and helped scores of innovative companies by providing capital, research and development strategies, business development strategies, strategic consulting and board membership.
- Joseph received a BS from Babson College in finance and entrepreneurial studies in 1992.